PCM
Penserra Capital Management Portfolio holdings
AUM
$7.17B
1-Year Return
49.58%
This Quarter Return
+9.42%
1 Year Return
+49.58%
3 Year Return
+118.16%
5 Year Return
+229.83%
10 Year Return
–
AUM
$5.41B
AUM Growth
+$1.18B
(+28%)
Cap. Flow
+$972M
Cap. Flow
% of AUM
17.96%
Top 10 Holdings %
Top 10 Hldgs %
20.49%
Holding
1,158
New
152
Increased
697
Reduced
246
Closed
52
Top Buys
| 1 |
Alibaba
BABA
|
$59.8M |
| 2 |
JD.com
JD
|
$41.3M |
| 3 |
Mercado Libre
MELI
|
$35.1M |
| 4 |
NetEase
NTES
|
$34.7M |
| 5 |
KE Holdings
BEKE
|
$19.5M |
Top Sells
| 1 |
Futu Holdings
FUTU
|
$27.8M |
| 2 |
Trip.com Group
TCOM
|
$21.9M |
| 3 |
AOD
abrdn Total Dynamic Dividend Fund
AOD
|
$12.1M |
| 4 |
Gabelli Dividend & Income Trust
GDV
|
$12M |
| 5 |
EFR
Eaton Vance Senior Floating-Rate Fund
EFR
|
$11.2M |
Sector Composition
| 1 | Consumer Discretionary | 33.74% |
| 2 | Technology | 22.72% |
| 3 | Communication Services | 13.35% |
| 4 | Industrials | 4.85% |
| 5 | Real Estate | 4.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLUE
826
DELISTED
bluebird bio
BLUE
| $45K | ﹤0.01% |
117
-2
| -2% | -$769 |
|
827
Enphase Energy
ENPH
$5.18B
| $45K | ﹤0.01% |
281
+43
| +18% | +$6.89K |
|
828
Expeditors International
EXPD
$16.4B
| $45K | ﹤0.01% |
418
+64
| +18% | +$6.89K |
|
829
W.W. Grainger
GWW
$47.5B
| $44K | ﹤0.01% |
111
+16
| +17% | +$6.34K |
|
|
IGMS
830
DELISTED
IGM Biosciences
IGMS
| $44K | ﹤0.01% |
575
+20
| +4% | +$1.53K |
|
831
Waters Corp
WAT
$18.2B
| $44K | ﹤0.01% |
155
+24
| +18% | +$6.81K |
|
|
RVNC
832
DELISTED
Revance Therapeutics, Inc.
RVNC
| $44K | ﹤0.01% |
1,610
+85
| +6% | +$2.32K |
|
|
DRNA
833
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $44K | ﹤0.01% |
1,725
+5
| +0.3% | +$128 |
|
834
Broadridge
BR
$29.4B
| $43K | ﹤0.01% |
283
+40
| +16% | +$6.08K |
|
835
Inovio Pharmaceuticals
INO
$148M
| $43K | ﹤0.01% |
390
+61
| +19% | +$6.73K |
|
836
MarketAxess Holdings
MKTX
$7.01B
| $43K | ﹤0.01% |
88
+12
| +16% | +$5.86K |
|
837
Seagate
STX
$40B
| $43K | ﹤0.01% |
563
+88
| +19% | +$6.72K |
|
|
COUP
838
DELISTED
Coupa Software Incorporated
COUP
| $43K | ﹤0.01% |
171
+27
| +19% | +$6.79K |
|
|
CTXS
839
DELISTED
Citrix Systems Inc
CTXS
| $43K | ﹤0.01% |
310
+50
| +19% | +$6.94K |
|
840
Kura Oncology
KURA
$713M
| $42K | ﹤0.01% |
1,495
+195
| +15% | +$5.48K |
|
841
Seres Therapeutics
MCRB
$169M
| $42K | ﹤0.01% |
103
-2
| -2% | -$816 |
|
842
Madrigal Pharmaceuticals
MDGL
$9.65B
| $42K | ﹤0.01% |
365
+5
| +1% | +$575 |
|
843
Markel Group
MKL
$24.2B
| $42K | ﹤0.01% |
37
+8
| +28% | +$9.08K |
|
844
Tyler Technologies
TYL
$24.2B
| $42K | ﹤0.01% |
100
+16
| +19% | +$6.72K |
|
845
Genuine Parts
GPC
$19.4B
| $41K | ﹤0.01% |
361
+56
| +18% | +$6.36K |
|
846
Fair Isaac
FICO
$36.8B
| $40K | ﹤0.01% |
83
+19
| +30% | +$9.16K |
|
847
Ironwood Pharmaceuticals
IRWD
$188M
| $40K | ﹤0.01% |
3,650
-80
| -2% | -$877 |
|
848
MacroGenics
MGNX
$126M
| $40K | ﹤0.01% |
1,270
-40
| -3% | -$1.26K |
|
849
BioCryst Pharmaceuticals
BCRX
$1.74B
| $40K | ﹤0.01% |
4,000
-120
| -3% | -$1.2K |
|
850
NetApp
NTAP
$23.7B
| $40K | ﹤0.01% |
558
+88
| +19% | +$6.31K |
|